Kairos Pharma Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.46

-0.02 (-5.04%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +1,661.6% upside

Low Target $5.03

Average Target $8.04

High Target $9.33

Current Price $0.46

Current
$0.46

Target
$8.04

$5.03 $8.04 avg $9.33

Scenario Analysis

Bear Case

$5.03

1,002.1%

Low target

Base Case

$8.04

+1,661.6%

Avg target

Bull Case

$9.33

+1,944.3%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$7.28

-93.7% from high

52-Week Low

$0.42

+9.1% from low

Target vs 52W High

$8.04

+10.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%